LegoChem
Scope
Date
~
-
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio mulls name change after defeat to Lego
South Korean biopharmaceutical company LegoChem Biosciences Inc. is seeking to change its name after it lost in a trademark infringement lawsuit fil...
Dec 08, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio receives FDA approval for phase 1,2 trials of LCB84
South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...
Jun 23, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Biotech
LegoChem’s biotech platform drives 28% share price spike over last month
The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...
Jul 07, 2021 (Gmt+09:00)
language